Dr. Vanessa L. Prowler, MD

Dr. Prowler practices at Lakeland Regional Health Systems, Inc. in Lakeland, Florida.

Dr. Prowler's NPI, 1801115241, was assigned on May 25, 2010. Dr. Prowler graduated from Florida State University College Of Medicine in 2010. Dr. Prowler holds Florida license ME115554.

Dr. Prowler's primary practice is Lakeland Regional Health Systems, Inc., at 3525 Lakeland Hills Blvd, Lakeland, FL 33805 in Polk County. The practice phone is (863) 687-7251.

Dr. Prowler's primary practice is Lakeland Regional Health Systems, Inc. in Lakeland, Florida. Dr. Prowler is also affiliated with Lakeland Regional Health Medical Center. The medical group on file is Lakeland Regional Health. Dmand AI also links Dr. Prowler to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Prowler practices, 2 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Prowler's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Prowler is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Prowler's licenses on file in 2 states: Florida and New York.

Dmand AI lists mastectomy among the conditions Dr. Prowler treats.

CMS data shows 369 Medicare services from Dr. Prowler across 14 procedure codes in 2024, for 118 Medicare patients. Medicare paid $51,368 for them.

CMS counts 118 Medicare patients who saw Dr. Prowler in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have cancer, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Prowler's median patient age at 62, with 98% women.

In 2024, Dr. Prowler wrote 322 Medicare Part D claims for 192 patients. 100% of them were for generic drugs. CMS names the drug for 253 of them, across 6 drugs with 11 or more claims each, at $1,916 in total drug cost. In 2023, CMS named 347 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Prowler for performance year 2024, reported as part of a group. Dr. Prowler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 23 procedures of mastectomy by Dr. Prowler, more than 81% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Prowler in 2014. 2014 was the busiest year, with 2. Dr. Prowler's most frequent co-authors are Nazanin I. Khakpour, MD, John Vincent Kiluk, MD and Christine Laronga, MD.

CMS Open Payments shows 24 general payments to Dr. Prowler from 12 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 51% of the total. Medtronic USA, Inc. paid the most, $1,173.

Dmand AI lists 4 awards for Dr. Prowler, most recently Certified Genetics Cancer Risk Assessment Provider, Certificate in Clinical Cancer Genomics Risk Assessment in 2020. Dr. Prowler serves on Lakeland Florida NAPBC, Lakeland Regional Health Committee on Cancer and Lakeland Surgical and Diagnostic Center Quality Committee.

Dr. Prowler graduated from Florida State University College Of Medicine in 2010. Dr. Prowler is a member of ACS, ASBS and SSO.

Dr. Prowler is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.